Delivery Order HHSN272201500006I-HHSN27200002
Award Date
9/15/15
Potential Completion Date
8/31/17
Potential Value
$417K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Duke University
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Duke University, a private university and non-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services (HHS). The contract is a Delivery Order under the "Therapeutics Against Infectious Diseases Phase 1" indefinite delivery/indefinite quantity (IDIQ) contract vehicle, with a ceiling value of $212,814.70....
This is a cost-plus-fixed-fee delivery order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Duke University for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The potential value of the award is $126,086.19. The order was issued against the Therapeutics Against Infectious Diseases Phase 1 master contract. No set-aside designation was used. As the prime contractor, Duke University will provide clinical...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University. The contract is for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases and has a ceiling value of $127,244.88. It is a delivery order awarded under the Therapeutics Against Infectious Diseases Phase 1 contract vehicle. The contract does not have a set-aside designation. Duke University, a private non-profit educational...
This federal contract award is for a $109,969 Phase 1 Clinical Trial to be conducted by Duke University Office of Research Administration Division for the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases. The contract is a delivery order against the parent Therapeutics Against Infectious Diseases Phase 1 multiple-award IDIQ contract. Duke University, a private non-profit research university, is the prime...
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University under the NIAID Animal Models of Infectious Diseases 2010-2017 indefinite delivery indefinite quantity (IDIQ) contract. The $50,000 order is for Duke University to provide animal models of infectious diseases. No set-aside designation was used for this award. Duke University's Office of Research Administration Division serves as the prime...
This federal contract award is for a Phase 1 clinical trial protocol development, implementation, and research laboratory analysis task for a therapeutic against malaria. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University for $40,257. This task is part of the Therapeutics Against Infectious Diseases Phase 1 contract vehicle, which is a larger program supporting the development of therapeutics against infectious...
Duke University has been awarded a cost-no-fee task order valued at $10.38 million by the National Institutes of Health National Institute of Allergy and Infectious Diseases. The task order was issued against Duke University's existing preclinical and translational vaccine development IDIQ with the agency. Under this task order, Duke University will provide services and materials to support in vitro transcription reactions, mRNA purification, and procurement of lipid raw materials for...
This is a federal contract award to Duke University, a private university, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports clinical research on vaccines and treatments for infectious diseases. The specific award is for Task B1C1 under contract HHSN272201300017I, with a ceiling value of $1,154,053.22. The award date was...
This is a federal contract award to Duke University by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), a civilian agency. The award is a $3,190,344.25 delivery order under the Vaccine and Treatment Evaluation Units (VTEU) indefinite delivery, indefinite quantity (IDIQ) contract. The contract is for clinical research and immunization safety assessment services related to vaccines and treatments for infectious diseases. This...
This is a Delivery Order under the "Phase I Clinical Trials for Development of Neurotherapeutics" Indefinite Delivery Indefinite Quantity (IDIQ) contract, awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Duke University. The contract is for administrative and overall clinical operations support under NIDA's Phase I clinical trials program for developing neurotherapeutics. The fixed-price delivery order has a ceiling value of $409,541.00 and a period of...